Pancreatic Tumor Model
Pancreatic Tumor Model - Related Videos
03:59
Orthotopic Homograft Tumor Transplantation: A Technique to Generate Pancreatic Tumor Mouse Models
0 Views •
2023
The video explains a stepwise surgical method for orthotopic implantation of a tumor fragment from a cancerous donor to the pancreas of a non-cancerous recipient mice for development of pancreatic cancer. Orthotopically implanted PDAC could recapture the tissue microenvironment of human pancreatic cancers than conventional subcutaneous (SC) models more accurately.
09:18
Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
0 Views •
2026
This protocol uses a multichamber bed for parallel magnetic resonance imaging (MRI) of up to four animals to detect pancreatic adenocarcinoma tumors in genetically engineered mouse models. This multianimal MRI protocol is fast and cost-effective for detecting and measuring tumors, facilitating animal selection for preclinical studies and longitudinal monitoring of tumor growth.
09:25
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
0 Views •
Cited by 34 •
2013
Improved understanding of pancreatic cancer biology is critically needed to enable the development of better therapeutic options to treat pancreatic cancer. To address this need, we demonstrate an orthotopic model of pancreatic cancer that permits non-invasive monitoring of cancer progression using in vivo bioluminescence imaging.
03:50
Irreversible Electroporation: A Technique for Ablating Pancreatic Tumor in Mouse
0 Views •
2023
This video describes the procedure for performing irreversible electroporation (IRE) for non-thermal ablation of pancreatic tumors in mice. Both subcutaneous (SQ) and orthotopic tumors can be successfully treated with IRE in a highly controlled setting, facilitating various studies post-procedure.
05:11
Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
0 Views •
2026
This article presents laparoscopic central pancreatectomy with pancreatic duct end-to-end anastomosis as an important surgical approach for middle-segment pancreatic benign and low-grade malignant tumors.
FAQs
Cell-based systems allow researchers to study tumor behavior under controlled culture conditions, while patient-derived organoids can retain features of individual tumors. Implanted tumors add a living host context in which interactions with the extracellular matrix, stromal cells, and immune components can be examined. Together, these formats connect simplified experimental observations with more complex tumor behavior.
These components provide biological context beyond the tumor cells themselves. Their interactions can influence how a tumor grows, invades surrounding areas, responds to treatment, or develops resistance. Models that preserve these relationships help researchers examine pancreatic cancer as a multicellular system, rather than interpreting drug sensitivity or tumor behavior from isolated cells alone.
Controlled cultures make it possible to examine tumor-cell behavior under defined experimental conditions, whereas living-host models provide a setting that includes broader interactions around an implanted tumor. Comparing both can help relate molecular findings to observable growth, invasion, drug sensitivity, and treatment resistance, while showing how experimental context affects the interpretation of results.
Researchers can expose model systems to treatments and examine changes in tumor growth, invasion, or drug sensitivity. These observations can then be related to molecular findings to investigate why a treatment may not produce the expected response. Including stromal, extracellular-matrix, or immune interactions can provide additional context for resistance mechanisms when those components are preserved.
A study generally begins by selecting a suitable system, such as tumor cells, a patient-derived organoid, or an implanted tumor, according to the biological question. Researchers then maintain the model under controlled culture conditions or in a living host, apply the treatment or comparison of interest, and assess tumor growth, invasion, drug sensitivity, or resistance.
They are useful when investigators need to connect molecular mechanisms with measurable tumor behavior before evaluating a treatment more broadly. These systems support preclinical studies of disease biology, treatment response, and resistance. Patient-derived organoids may also help examine differences between tumors, contributing to research aimed at developing more effective and individualized therapies.